Ivivi Technologies to Present at Noble Financial Two Double-0-Seven Conference, August 20, 2007
August 16 2007 - 8:30AM
Business Wire
Ivivi Technologies, Inc. (AMEX:II), today announced that Andr�
DiMino, Vice Chairman and Co-CEO, and David Saloff, President and
Co-CEO, are scheduled to present a corporate overview at the Noble
Financial Equity Conference on August 20, 2007 at the Charleston
Place Hotel in Charleston, South Carolina. Management will also
participate in a question and answer session following the
presentation and one-on-one meetings throughout the day. Ivivi
Technologies� presentation is scheduled for 10:00 am Eastern Time.
Individuals interested in listening to the live presentation can
participate by going to the Investor Relations section of the
Company�s website www.ivivitechnologies.com under Events and
Presentations or by going to Noble Financial�s conference website
at www.two-007.net. It is recommended that interested parties
register at least 15 minutes prior to the start of the presentation
to ensure timely access. A replay of the webcast will also be
available for 90 days. About Ivivi Technologies, Inc. Based in
Northvale, NJ, Ivivi Technologies, Inc. is a medical technology
company focusing on designing, developing and commercializing its
proprietary electrotherapeutic technology platform. Ivivi�s
research and development activities are focused specifically on
pulsed electromagnetic field, or PEMF, technology, which, by
creating a therapeutic electrical current in injured soft tissue,
stimulates biochemical and physiological healing processes to help
repair the injured tissue and reduce related pain and inflammation.
The Company�s Electroceuticals� have been used in non-invasive
treatments for a wide array of conditions, including chronic
wounds, pain and edema following plastic and reconstructive surgery
and chronic inflammatory disorders. About Noble Financial Noble
Financial is a privately-held, full-service capital markets firm
driven by what is often overlooked by other firms - uncovering the
value embedded in the orphaned, undiscovered or misunderstood
company. The company focuses on converting market inefficiencies
into profit opportunities. Noble Financial supports emerging
companies through strategic advice, investment banking,
market-making, sales & trading, comprehensive equity research,
and the development of institutional support. Noble Financial�s
equity conferences � 2007 marks their third annual - allow for a
unique blend of professional and personal interaction among a
diverse cross-section of executives. The company has operated for
23 years and has offices in Florida and New York City. Conference
Information: www.two-007.net or info@two-007.net Investor
Registration: www.two-007.net/RegistrationInvestorBuyside.htm Noble
Financial Website: www.nobleresearch.com Forward-Looking Statements
This release contains "forward-looking statements" made pursuant to
the safe harbor provisions of the Private Securities Litigation
Reform Act of 1995 including those related to our cardiac study at
the Cleveland Clinic, strategic partnerships and future sales.
Forward-looking statements reflect management's current knowledge,
assumptions, judgment and expectations regarding future performance
or events. Although management believes that the expectations
reflected in such statements are reasonable, they give no assurance
that such expectations will prove to be correct and you should be
aware that actual results could differ materially from those
contained in the forward-looking statements. Forward-looking
statements are subject to a number of risks and uncertainties,
including, but not limited to, the Company�s limited operating
history, history of significant and continued operating losses and
substantial accumulated earnings deficit, difficulties with its
financial accounting controls, the failure of the market for the
Company�s products to continue to develop, the inability for
customers to receive third party reimbursement, the inability to
obtain additional capital, the inability to protect the Company�s
intellectual property, the loss of any executive officers or key
personnel or consultants, competition, changes in the regulatory
landscape or the imposition of regulations that affect the
Company�s products and other risks detailed from time to time in
the Company�s filings with the Securities and Exchange Commission,
including the Company�s Form 10-KSB for the fiscal year ended March
31, 2007. The Company assumes no obligation to update the
information contained in this press release.
Equifin (AMEX:II)
Historical Stock Chart
From Aug 2024 to Sep 2024
Equifin (AMEX:II)
Historical Stock Chart
From Sep 2023 to Sep 2024